Our Pipeline
Driving significant value
for patients.
-
Discovery
We are discovering transformational medicines for patients that need them, starting with bone-related diseases.
-
Focus
We focus on diseases where our technology can add significant value, and look for opportunities where there is a validated translational path to the clinic.
-
Advancement
We are rapidly advancing programmes in bone disease using insights from our technology and data, including our proprietary functional single-cell atlas Osteomics.
Our technology has applicability to a wide range of diseases.
Beyond bone, our interdisciplinary teams are developing programmes in, for example, immunology and metabolic disease.
Osteoporosis
- Over 45 million patients across the US, Europe and Japan.
- Affects one in two women and one in four men over 50.
- An inherited disease with over 2,000 gene loci identified to date.
- High translational fidelity from patient to lab to patient.
- Discovery driven by Relation’s proprietary bone atlas, Osteomics.
Osteomics: the world’s largest functional, single-cell bone atlas.
A clinical observational study to develop a fundamental understanding of cellular bone homeostasis using patient-derived samples.
-
Deeply characterised samples using single-cell, spatial omics, imaging, genomics, proteomics and clinical phenotype.
-
Uncovering new biology, therapeutic targets, biomarkers and patient subgroups.
-
Hospitals and partners across the UK and Australia.
Discover and develop transformational medicines.
Join our compassionate team of experts committed to making a true difference to patient lives.